IBEX LTD (IBEX) Stock Fundamental Analysis
NASDAQ:IBEX - Nasdaq - BMG4690M1010 - Common Stock - Currency: USD
We assign a fundamental rating of 7 out of 10 to IBEX. IBEX was compared to 82 industry peers in the IT Services industry. IBEX gets an excellent profitability rating and is at the same time showing great financial health properties. IBEX is valued quite cheap, while showing a decent growth score. This is a good combination! With these ratings, IBEX could be worth investigating further for value and quality investing!.
1. Profitability
1.1 Basic Checks
In the past year IBEX was profitable.
In the past year IBEX had a positive cash flow from operations.
IBEX had positive earnings in each of the past 5 years.
IBEX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
IBEX has a Return On Assets of 13.51%. This is amongst the best in the industry. IBEX outperforms 93.90% of its industry peers.
IBEX's Return On Equity of 29.89% is amongst the best of the industry. IBEX outperforms 93.90% of its industry peers.
The Return On Invested Capital of IBEX (18.65%) is better than 91.46% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IBEX is significantly below the industry average of 22.80%.
The last Return On Invested Capital (18.65%) for IBEX is above the 3 year average (12.81%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.51% | ||
| ROE | 29.89% | ||
| ROIC | 18.65% |
ROA(3y)9.84%
ROA(5y)7.66%
ROE(3y)20.09%
ROE(5y)24.99%
ROIC(3y)12.81%
ROIC(5y)12.8%
1.3 Margins
IBEX's Profit Margin of 6.93% is fine compared to the rest of the industry. IBEX outperforms 67.07% of its industry peers.
IBEX's Profit Margin has improved in the last couple of years.
With a decent Operating Margin value of 8.88%, IBEX is doing good in the industry, outperforming 63.41% of the companies in the same industry.
In the last couple of years the Operating Margin of IBEX has grown nicely.
IBEX has a Gross Margin (30.89%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of IBEX has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.88% | ||
| PM (TTM) | 6.93% | ||
| GM | 30.89% |
OM growth 3Y29.52%
OM growth 5Y35.17%
PM growth 3Y30.84%
PM growth 5Y17.25%
GM growth 3Y17.46%
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), IBEX is creating value.
Compared to 1 year ago, IBEX has less shares outstanding
Compared to 5 years ago, IBEX has less shares outstanding
The debt/assets ratio for IBEX is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 4.35 indicates that IBEX is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 4.35, IBEX is doing good in the industry, outperforming 70.73% of the companies in the same industry.
IBEX has a debt to FCF ratio of 1.04. This is a very positive value and a sign of high solvency as it would only need 1.04 years to pay back of all of its debts.
The Debt to FCF ratio of IBEX (1.04) is better than 80.49% of its industry peers.
IBEX has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.16, IBEX is doing good in the industry, outperforming 65.85% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | 1.04 | ||
| Altman-Z | 4.35 |
ROIC/WACC1.89
WACC9.87%
2.3 Liquidity
A Current Ratio of 1.67 indicates that IBEX should not have too much problems paying its short term obligations.
IBEX has a Current ratio (1.67) which is comparable to the rest of the industry.
IBEX has a Quick Ratio of 1.67. This is a normal value and indicates that IBEX is financially healthy and should not expect problems in meeting its short term obligations.
IBEX's Quick ratio of 1.67 is in line compared to the rest of the industry. IBEX outperforms 56.10% of its industry peers.
IBEX does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.67 | ||
| Quick Ratio | 1.67 |
3. Growth
3.1 Past
IBEX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.22%, which is quite impressive.
The Earnings Per Share has been growing by 25.59% on average over the past years. This is a very strong growth
Looking at the last year, IBEX shows a small growth in Revenue. The Revenue has grown by 5.38% in the last year.
IBEX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.66% yearly.
EPS 1Y (TTM)34.22%
EPS 3Y18.32%
EPS 5Y25.59%
EPS Q2Q%17.14%
Revenue 1Y (TTM)5.38%
Revenue growth 3Y4.68%
Revenue growth 5Y6.66%
Sales Q2Q%10.99%
3.2 Future
The Earnings Per Share is expected to grow by 17.83% on average over the next years. This is quite good.
IBEX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.63% yearly.
EPS Next Y24.13%
EPS Next 2Y21.44%
EPS Next 3Y17.83%
EPS Next 5YN/A
Revenue Next Year7.46%
Revenue Next 2Y6.63%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 10.94, the valuation of IBEX can be described as reasonable.
Based on the Price/Earnings ratio, IBEX is valued cheaply inside the industry as 90.24% of the companies are valued more expensively.
IBEX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.03.
A Price/Forward Earnings ratio of 8.79 indicates a reasonable valuation of IBEX.
Based on the Price/Forward Earnings ratio, IBEX is valued cheaper than 91.46% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of IBEX to the average of the S&P500 Index (36.28), we can say IBEX is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.94 | ||
| Fwd PE | 8.79 |
4.2 Price Multiples
92.68% of the companies in the same industry are more expensive than IBEX, based on the Enterprise Value to EBITDA ratio.
70.73% of the companies in the same industry are more expensive than IBEX, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.63 | ||
| EV/EBITDA | 5.54 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IBEX has an outstanding profitability rating, which may justify a higher PE ratio.
IBEX's earnings are expected to grow with 17.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.45
PEG (5Y)0.43
EPS Next 2Y21.44%
EPS Next 3Y17.83%
5. Dividend
5.1 Amount
No dividends for IBEX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:IBEX (8/6/2025, 10:53:55 AM)
27.47
-0.42 (-1.51%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners93.39%
Inst Owner Change-0.97%
Ins Owners9.78%
Ins Owner Change-9.32%
Market Cap367.27M
Analysts45.71
Price Target31.11 (13.25%)
Short Float %1.51%
Short Ratio1.34
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.71%
Min EPS beat(2)10.89%
Max EPS beat(2)14.54%
EPS beat(4)4
Avg EPS beat(4)10.27%
Min EPS beat(4)7.33%
Max EPS beat(4)14.54%
EPS beat(8)6
Avg EPS beat(8)4.12%
EPS beat(12)9
Avg EPS beat(12)12.36%
EPS beat(16)11
Avg EPS beat(16)11.12%
Revenue beat(2)2
Avg Revenue beat(2)3.78%
Min Revenue beat(2)2.45%
Max Revenue beat(2)5.12%
Revenue beat(4)3
Avg Revenue beat(4)2.25%
Min Revenue beat(4)-0.14%
Max Revenue beat(4)5.12%
Revenue beat(8)3
Avg Revenue beat(8)-0.13%
Revenue beat(12)3
Avg Revenue beat(12)-1.53%
Revenue beat(16)5
Avg Revenue beat(16)-1.36%
PT rev (1m)0%
PT rev (3m)17.31%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.41%
EPS NY rev (1m)1.18%
EPS NY rev (3m)1.98%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.88%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.49%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.94 | ||
| Fwd PE | 8.79 | ||
| P/S | 0.69 | ||
| P/FCF | 18.63 | ||
| P/OCF | 10.45 | ||
| P/B | 2.96 | ||
| P/tB | 3.27 | ||
| EV/EBITDA | 5.54 |
EPS(TTM)2.51
EY9.14%
EPS(NY)3.13
Fwd EY11.38%
FCF(TTM)1.47
FCFY5.37%
OCF(TTM)2.63
OCFY9.57%
SpS40.06
BVpS9.29
TBVpS8.4
PEG (NY)0.45
PEG (5Y)0.43
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.51% | ||
| ROE | 29.89% | ||
| ROCE | 25.63% | ||
| ROIC | 18.65% | ||
| ROICexc | 19.91% | ||
| ROICexgc | 21.22% | ||
| OM | 8.88% | ||
| PM (TTM) | 6.93% | ||
| GM | 30.89% | ||
| FCFM | 3.68% |
ROA(3y)9.84%
ROA(5y)7.66%
ROE(3y)20.09%
ROE(5y)24.99%
ROIC(3y)12.81%
ROIC(5y)12.8%
ROICexc(3y)17.21%
ROICexc(5y)17.42%
ROICexgc(3y)18.84%
ROICexgc(5y)20.06%
ROCE(3y)15.96%
ROCE(5y)15.95%
ROICexcg growth 3Y4.28%
ROICexcg growth 5Y9.56%
ROICexc growth 3Y7.35%
ROICexc growth 5Y13.69%
OM growth 3Y29.52%
OM growth 5Y35.17%
PM growth 3Y30.84%
PM growth 5Y17.25%
GM growth 3Y17.46%
GM growth 5YN/A
F-Score6
Asset Turnover1.95
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | 1.04 | ||
| Debt/EBITDA | 0.3 | ||
| Cap/Depr | 87.74% | ||
| Cap/Sales | 2.88% | ||
| Interest Coverage | 34.97 | ||
| Cash Conversion | 53.93% | ||
| Profit Quality | 53.13% | ||
| Current Ratio | 1.67 | ||
| Quick Ratio | 1.67 | ||
| Altman-Z | 4.35 |
F-Score6
WACC9.87%
ROIC/WACC1.89
Cap/Depr(3y)96.17%
Cap/Depr(5y)91.5%
Cap/Sales(3y)3.54%
Cap/Sales(5y)3.32%
Profit Quality(3y)72.8%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.22%
EPS 3Y18.32%
EPS 5Y25.59%
EPS Q2Q%17.14%
EPS Next Y24.13%
EPS Next 2Y21.44%
EPS Next 3Y17.83%
EPS Next 5YN/A
Revenue 1Y (TTM)5.38%
Revenue growth 3Y4.68%
Revenue growth 5Y6.66%
Sales Q2Q%10.99%
Revenue Next Year7.46%
Revenue Next 2Y6.63%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.55%
EBIT growth 3Y35.57%
EBIT growth 5Y44.18%
EBIT Next Year91.11%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-42.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-32.37%
OCF growth 3Y30.7%
OCF growth 5Y74.8%